Showing 1 - 10 of 1,835
Persistent link: https://www.econbiz.de/10010465082
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and … keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external … knowledge, which helps improve their internal drug development capability. Our study examines the dynamic effects of licensing …
Persistent link: https://www.econbiz.de/10012219514
, has been a focus for these large MNC's scouting for licensing new drugs. This work analyses the licensing activities that …
Persistent link: https://www.econbiz.de/10012994958
There are several determinants that could have an effect on in-licensing decisions by a pharmaceutical or biotech firm …. This work studies over 200 licensing deals involving big pharma companies in the period (2011 – 2015) and identifies … different factors that could play a role in licensing deals, and classifies these determinants into direct determinants and …
Persistent link: https://www.econbiz.de/10014033016
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian … as under counterfactual policy scenarios such as compulsory licensing whereby the government forcibly assigns the right … pricing and licensing strategies by the patent holders. Our results indicate that differential pricing and voluntary licensing …
Persistent link: https://www.econbiz.de/10013035611
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...
Persistent link: https://www.econbiz.de/10012064786
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733
related to this case. An assessment of the compulsory licensing provisions under the TRIPS agreement and the Indian Patent Act …
Persistent link: https://www.econbiz.de/10010211996
This paper analyzes the impact of patent bibliographic indicators and patent characteristics on the economic value of patents put on sale in an auction, considering different typologies of sellers and buyers. A unique dataset covering all patent auctions held until the end of 2008 by Ocean Tomo...
Persistent link: https://www.econbiz.de/10014155821
Universities are engines of innovation. To encourage further innovation, the federal government and charitable foundations give universities grants in order to enable university researchers to produce the inventions and discoveries that will continue to fuel our knowledge economy. Among other...
Persistent link: https://www.econbiz.de/10014104720